DOI: 10.1128/AAC.04181-14
Article Information
PubMed
Published By
History
- Received August 28, 2014
- Returned for modification October 1, 2014
- Accepted October 30, 2014
- Published online December 23, 2014.
Copyright & Usage
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (November 03, 2014).
- You are viewing the most recent version of this article.
Author Information
- Mateusz M. Plucinskia,b,
- Eldin Talundzica,
- Lindsay Mortona,
- Pedro Rafael Dimbuc,
- Aleixo Panzo Macaiad,
- Filomeno Fortesc,
- Ira Goldmana,
- Naomi Lucchia,
- Gail Stenniesa,
- John R. MacArthura and
- Venkatachalam Udhayakumara
- aMalaria Branch and President's Malaria Initiative, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- bEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- cNational Malaria Control Program, Ministry of Health, Luanda, Angola
- dField Epidemiology and Laboratory Training Program, Ministry of Health, Luanda, Angola
- Address correspondence to Mateusz M. Plucinski, mplucinski{at}cdc.gov.
Citation Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V. 2015. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, Angola. Antimicrob Agents Chemother 59:437–443. doi:10.1128/AAC.04181-14.
